Clinical Trials Directory

Trials / Sponsors / Clovis Oncology, Inc.

Clovis Oncology, Inc.

Industry · 14 registered clinical trials.

StatusTrialPhaseStarted
SuspendedA Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
Advanced Solid Tumor, Gynecologic Cancer
Phase 1 / Phase 22019-07-29
TerminatedA Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanc
Non-small Cell Lung Cancer
Phase 1 / Phase 22016-02-24
TerminatedPhase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGF
Non-small Cell Lung Cancer
Phase 1 / Phase 22015-09-30
TerminatedTIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Che
Non-small Cell Lung Cancer
Phase 32015-02-01
TerminatedTIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastat
Non-Small Cell Lung Cancer
Phase 2 / Phase 32014-11-01
TerminatedA Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With
Breast Cancer, Metastatic Breast Cancer, MBC
Phase 22014-09-09
TerminatedMulticenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell L
Non-small Cell Lung Cancer
Phase 22014-06-16
TerminatedA Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advan
Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer, NSCLC
Phase 22014-04-01
TerminatedA Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin
Solid Tumor, Non-small-cell Lung Cancer, Lung Cancer
Phase 12012-07-01
TerminatedStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant
Locally Advanced or Metastatic Non Small Cell Lung Cancer
Phase 1 / Phase 22012-03-27
CompletedSafety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12011-04-01
CompletedStudy to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Ad
Metastatic Pancreatic Adenocarcinoma
Phase 22011-04-01
CompletedA Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenoc
Metastatic Pancreatic Adenocarcinoma
Phase 22010-05-01
No Longer AvailableRociletinib (CO-1686) USA Expanded Access Program
Non-small Cell Lung Cancer
——